Better: Rctd-031

The authors thank the U.S. Department of Energy (Office of Energy Efficiency and Renewable Energy) for funding under Grant DE‑EE0001234, and the International Center for Metasurface Research for providing access to nanofabrication facilities.

The TE stack consists of arranged in a series‑parallel configuration, delivering a total internal resistance of 0.42 Ω. The legs are sandwiched between graphene‑reinforced AlN ceramic plates that provide high mechanical strength and minimal thermal shunting (k≈12 W m⁻¹ K⁻¹). rctd-031

Allosteric modulation offers a “tune‑down” effect rather than a complete shut‑off, which is believed to minimize off‑target toxicity while preserving enough basal signaling for normal tissue maintenance. The authors thank the U

The biotech landscape is constantly evolving, and just when we thought we’d seen the limits of precision medicine, a new candidate steps onto the stage: . First disclosed in a brief press release from Renaissance Therapeutics earlier this year, RCTD‑031 promises to bring a novel mechanism of action to a handful of hard‑to‑treat diseases. In this post we’ll break down what’s publicly known about RCTD‑031, why it matters, and what the next milestones look like for patients, clinicians, and investors. First disclosed in a brief press release from